FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080512753> ?p ?o ?g. }

• W2080512753 endingPage "951" @default.
• W2080512753 startingPage "941" @default.
• W2080512753 abstract "Few data are available from large population-based studies on survival and renal outcome of patients with renal involvement and different types of systemic amyloidosis.Two hundred and ninety of over 373 patients affected from systemic amyloidosis with renal involvement diagnosed in Italy between January 1995 and December 2000 were followed from diagnosis to death or until the last available clinical control. Eighty-three patients were excluded from analysis either because the amyloid type remained undetermined or they were lost at follow-up. Clinical and laboratory information was collected according to the different types of amyloidosis using a specific form which included renal function with 24 h proteinuria at diagnosis and at the end of follow-up, the type and the date of onset of dialysis and the kind of treatment they underwent.The median time of follow-up was 24 months in primary (AL) amyloidosis (range: 1-88 months), 16 months in AL with associated multiple myeloma (MM + AL: range 1-76 months), 30 months in reactive (AA) amyloidosis (range: 1-99 months) and 52 months in patients with familial forms (AF: range 14-82 months). Patients with AL showed a significantly shorter survival than AA. Despite no significant differences of renal outcome or survival on dialysis being observed between the two groups, a lower renal survival with a higher number of patients who progressed to end-stage renal disease (ESRD) was observed in patients with AA. Overall survival was markedly improved in patients with AL who underwent a specific therapy (conventional chemotherapy or autologous stem cell transplantation (ASCT)) even in the absence of a positive kidney response. Multivariate analysis showed cardiac involvement and specific therapy to significantly influence survival in AL whereas age, serum creatinine (sCr) and heart involvement significantly affected survival in AA. In both groups, sCr and heart involvement were the most relevant predictors for renal outcome, together with urinary protein excretion, in patients with AA.Our results show a worse survival in AL due to the higher prevalence of heart involvement in this group and emphasize that a specific therapy significantly prolongs survival and slows the progression of renal disease in patients with AL. We suggest that a late nephrological referral is likely the cause of the higher sCr found at presentation in patients with AA and probably accounts for the lower renal survival observed in the short term in these patients. At the time being, renal transplantation and ASCT are still rare therapeutic options for renal patients affected from systemic amyloidosis." @default.
• W2080512753 created "2016-06-24" @default.
• W2080512753 creator A5013854084 @default.
• W2080512753 creator A5017631227 @default.
• W2080512753 creator A5024215041 @default.
• W2080512753 creator A5030894931 @default.
• W2080512753 creator A5036341851 @default.
• W2080512753 creator A5046700667 @default.
• W2080512753 creator A5048909341 @default.
• W2080512753 creator A5061178305 @default.
• W2080512753 creator A5080444901 @default.
• W2080512753 creator A5040042136 @default.
• W2080512753 date "2007-10-15" @default.
• W2080512753 modified "2023-10-16" @default.
• W2080512753 title "Renal involvement in systemic amyloidosis: An Italian collaborative study on survival and renal outcome" @default.
• W2080512753 cites W178662434 @default.
• W2080512753 cites W1955975006 @default.
• W2080512753 cites W196488630 @default.
• W2080512753 cites W1975070907 @default.
• W2080512753 cites W2001594121 @default.
• W2080512753 cites W2012403164 @default.
• W2080512753 cites W2048521459 @default.
• W2080512753 cites W2066125924 @default.
• W2080512753 cites W2071134058 @default.
• W2080512753 cites W2080132976 @default.
• W2080512753 cites W2098093182 @default.
• W2080512753 cites W2103402325 @default.
• W2080512753 cites W2106283558 @default.
• W2080512753 cites W2116939662 @default.
• W2080512753 cites W2132984927 @default.
• W2080512753 cites W2143487376 @default.
• W2080512753 cites W2160240438 @default.
• W2080512753 cites W2169877938 @default.
• W2080512753 cites W2170517578 @default.
• W2080512753 cites W2313045125 @default.
• W2080512753 cites W2407569210 @default.
• W2080512753 cites W2490974417 @default.
• W2080512753 cites W2507060605 @default.
• W2080512753 doi "https://doi.org/10.1093/ndt/gfm684" @default.
• W2080512753 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17951308" @default.
• W2080512753 hasPublicationYear "2007" @default.
• W2080512753 type Work @default.
• W2080512753 sameAs 2080512753 @default.
• W2080512753 citedByCount "113" @default.
• W2080512753 countsByYear W20805127532012 @default.
• W2080512753 countsByYear W20805127532013 @default.
• W2080512753 countsByYear W20805127532014 @default.
• W2080512753 countsByYear W20805127532015 @default.
• W2080512753 countsByYear W20805127532016 @default.
• W2080512753 countsByYear W20805127532017 @default.
• W2080512753 countsByYear W20805127532018 @default.
• W2080512753 countsByYear W20805127532019 @default.
• W2080512753 countsByYear W20805127532020 @default.
• W2080512753 countsByYear W20805127532021 @default.
• W2080512753 countsByYear W20805127532022 @default.
• W2080512753 countsByYear W20805127532023 @default.
• W2080512753 crossrefType "journal-article" @default.
• W2080512753 hasAuthorship W2080512753A5013854084 @default.
• W2080512753 hasAuthorship W2080512753A5017631227 @default.
• W2080512753 hasAuthorship W2080512753A5024215041 @default.
• W2080512753 hasAuthorship W2080512753A5030894931 @default.
• W2080512753 hasAuthorship W2080512753A5036341851 @default.
• W2080512753 hasAuthorship W2080512753A5040042136 @default.
• W2080512753 hasAuthorship W2080512753A5046700667 @default.
• W2080512753 hasAuthorship W2080512753A5048909341 @default.
• W2080512753 hasAuthorship W2080512753A5061178305 @default.
• W2080512753 hasAuthorship W2080512753A5080444901 @default.
• W2080512753 hasConcept C126322002 @default.
• W2080512753 hasConcept C141071460 @default.
• W2080512753 hasConcept C159641895 @default.
• W2080512753 hasConcept C159654299 @default.
• W2080512753 hasConcept C203014093 @default.
• W2080512753 hasConcept C2776364478 @default.
• W2080512753 hasConcept C2777007455 @default.
• W2080512753 hasConcept C2778063415 @default.
• W2080512753 hasConcept C2779134260 @default.
• W2080512753 hasConcept C2779537928 @default.
• W2080512753 hasConcept C2779551797 @default.
• W2080512753 hasConcept C2779561371 @default.
• W2080512753 hasConcept C2779951007 @default.
• W2080512753 hasConcept C2779978075 @default.
• W2080512753 hasConcept C2780091579 @default.
• W2080512753 hasConcept C2908647359 @default.
• W2080512753 hasConcept C36394416 @default.
• W2080512753 hasConcept C71924100 @default.
• W2080512753 hasConcept C90924648 @default.
• W2080512753 hasConcept C99454951 @default.
• W2080512753 hasConceptScore W2080512753C126322002 @default.
• W2080512753 hasConceptScore W2080512753C141071460 @default.
• W2080512753 hasConceptScore W2080512753C159641895 @default.
• W2080512753 hasConceptScore W2080512753C159654299 @default.
• W2080512753 hasConceptScore W2080512753C203014093 @default.
• W2080512753 hasConceptScore W2080512753C2776364478 @default.
• W2080512753 hasConceptScore W2080512753C2777007455 @default.
• W2080512753 hasConceptScore W2080512753C2778063415 @default.
• W2080512753 hasConceptScore W2080512753C2779134260 @default.
• W2080512753 hasConceptScore W2080512753C2779537928 @default.
• W2080512753 hasConceptScore W2080512753C2779551797 @default.

• next